Skip to main content
logo
Altimmune logo
Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.305
-0.125 (-5.14%)
Oct 14, 2026, 12:53 PM EDT - Market open

Altimmune Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
448394513604808363
Market Cap Growth
29.58%-23.16%-15.16%-25.23%122.62%-12.91%
Enterprise Value
158199375464608165
Last Close Price
2.433.617.2111.2516.459.16

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-3.913.913.913.913.91
PS Ratio
14431.969610.9725640.431418.90-11888.9082.35
PB Ratio
1.001.754.153.114.361.82
P/TBV Ratio
0.941.754.153.114.681.95

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5068.704858.0118760.081090.28-37.39

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.080.160.010.000.010.01
Net Debt / Equity Ratio
-0.61-1.06-1.05-1.02-0.99-0.95
Net Debt / EBITDA Ratio
2.942.521.262.372.112.24
Net Debt / FCF Ratio
3.793.521.632.602.932.09
Asset Turnover
0000.00-0.02
Quick Ratio
26.3718.3512.9016.6910.9910.73
Current Ratio
26.7818.5513.1117.2611.3111.17
Return on Equity (ROE)
-28.88%-50.57%-59.86%-46.63%-44.07%-45.69%
Return on Assets (ROA)
-17.20%-28.17%-36.85%-25.00%-25.73%-22.86%
Return on Capital Employed (ROCE)
-19.20%-35.70%-80.10%-42.10%-46.20%-42.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-20.51%-22.36%-18.54%-14.63%-10.48%-26.74%
FCF Yield
-17.11%-17.14%-15.57%-12.55%-7.76%-24.88%
Buyback Yield / Dilution
-68.90%-24.08%-33.35%-13.47%-13.67%-61.03%
SEC Filings: 10-K · 10-Q